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NONALCOHOLIC HEPATIC STEATOSIS: ASSOCIATION 
WITH METABOLIC SYNDROME AND CARDIOVASCULAR 
RISK FACTORS IN OBESE ADOLESCENTS
Esteatose hepática não alcoólica: relação com a síndrome 
metabólica e os fatores de risco cardiovascular em adolescentes 
obesos
Esteatosis hepática no alcohólica: relación con el síndrome 
metabólico y los factores de riesgo cardiovascular en 
adolescentes obesos
ABSTRACT
Objective: To evaluate the association between nonalcoholic hepatic steatosis (NAHS), 
metabolic syndrome (MS) and cardiovascular risk factors (CRF) in obese adolescents. 
Methods: Cross-sectional observational study with a quantitative approach, carried out 
from June to August 2011. The volunteers were randomly selected and referred to clinical 
evaluation in the endocrinology and cardiology units at the clinics hospital of the Federal 
University of Uberlândia, being included 34 adolescents of 14-19 years above the 95th 
percentile of the growth curve. NAHS was assessed by ultrasonography. The MS and CRF 
were diagnosed by the International Diabetes Federation criteria. Results: The sample 
consisted of 14 male and 20 female patients aged 16.8 ± 1.6 and body mass index (BMI) of 
35.7 ± 3.9. The occurrence of NAHS and MS was 76.5% and 50%, respectively. Males had a 
higher incidence of NAHS (78.6%), SM (64.3%) and association of NAHS with MS (50%). 
Regarding the CRF, 100% (n=34), 61.8% (n=21) and 52.9% (n=18) of the adolescents had 
elevated values  of waist circumference (WC), low-density lipoprotein cholesterol (LDL-C) 
and systolic blood pressure (SBP), respectively, and 52.9% (n=18) showed low levels of 
high-density lipoprotein cholesterol (HDL-C). There were correlations between MS and 
triglycerides; systolic and diastolic blood pressure and HDL-C; and between NAHS and 
BMI and WC. Conclusion: A high occurrence of NAHS, SM and CRF was observed in 
obese adolescents. A strong correlation was observed between MS and NAHS, and between 
FRC and NAHS and SM. 
Descriptors: Adolescents; Obesity; Fatty Liver; Metabolic Syndrome X; Cardiovascular 
Diseases.
RESUMO
Objetivo: Avaliar a associação entre esteatose  hepática não alcoólica (EHNA), síndrome 
metabólica (SM) e fatores de risco cardiovascular (FRCs) em adolescentes obesos. Métodos: 
Estudo observacional do tipo transversal com abordagem quantitativa, realizado de junho 
a agosto de 2011. Os voluntários foram aleatoriamente selecionados e encaminhados 
para avaliação clínica no setor de endocrinologia e cardiologia do hospital de clínicas da 
Universidade Federal de Uberlândia. Participaram 34 adolescentes de 14 a 19 anos, acima 
do percentil 95 da curva de crescimento. A EHNA foi analisada por ultrassonografia. A 
SM e os FRCs foram identificados pelos critérios da International Diabetes Federation. 
Resultados: A amostra foi composta de 14 indivíduos do sexo masculino e 20 do sexo 
feminino, com idade (16,8±1,6) e índice de massa corporal (IMC) (35,7±3,9). A ocorrência 
de EHNA e SM foi de 76,5% (n=26) e 50% (n=17), respectivamente. O sexo masculino 
apresentou maior ocorrência de EHNA (78,6%, n=11), SM (64,3%, n=09) e associação 
de EHNA com SM (50%, n=07).  Em relação aos FRCs 100% (n=34), 61,8% (n=21) e 
52,9% (n=18) dos adolescentes apresentaram valores aumentados da circunferência da 
cintura (CC), da low-density-lipoprotein cholesterol (LDL-C) e pressão arterial sistólica 
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(PAS), respectivamente, e 52,9% (n=18) apresentaram baixos 
valores de high-density lipoprotein cholesterol (HDL-C). Houve 
correlações entre SM e triglicerídeos, PAS e diastólica e HDL-C, 
e entre EHNA, IMC e CC. Conclusão: Observou-se uma alta 
ocorrência de EHNA, SM e FRCs em adolescentes obesos. Uma 
forte correlação foi observada entre EHNA e SM, e entre FRCs 
com EHNA e SM. 
Descritores: Adolescentes; Obesidade Infantil; Fígado 
Gorduroso; Síndrome X Metabólica; Doenças Cardiovasculares.
RESUMEN
Objetivo: Evaluar la asociación entre la esteatosis hepática 
no alcohólica (EHNA), síndrome metabólico (SM) y factores 
de riesgo cardiovascular (FRCs) en adolescentes obesos. 
Métodos: Estudio observacional del tipo trasversal con 
abordaje cuantitativo realizado entre junio y agosto de 2011. Los 
voluntarios fueron seleccionados al azar y encaminados para 
evaluación clínica en el sector de endocrinología y cardiología del 
hospital de la Universidad Federal de Uberlandia. Participaron 
34 adolescentes entre 14 y 19 años que estaban por encima del 
percentil 95 de la curva de crecimiento. La EHNA fue analizada 
con la ultrasonografía. La SM y los FRCs fueron identificados 
a través de criterios de la International Diabetes Federtion. 
Resultados: La muestra fue constituida de 14 individuos del sexo 
masculino y 20 del sexo femenino con media de edad de 16,8±1,6 
años y media del índice de masa corporal (IMC) de 35,7±3,9. La 
ocurrencia de EHNA y SM fue del 76,5% (n=26) y 50% (n=17), 
respectivamente. El sexo masculino presentó mayor ocurrencia de 
EHNA (78,6%, n=11), SM (64,3%, n=09) y asociación de EHNA 
y SM (50%, n=07).  Respecto a los FRCs, el 100% (n=34), 61,8% 
(n=21) y el 52,9% (n=18) de los adolescentes presentaron valores 
mayores de la circunferencia de cintura (CC), de la low-density-
lipoprotein cholesterol (LDL-C) y tensión arterial sistólica 
(TAS), respectivamente, y el 52,9% (n=18) presentó bajos niveles 
de  high-density lipoprotein cholesterol (HDL-C). Hubieron 
correlaciones entre SM y triglicérides, TAS y diastólica y  HDL-C, 
y entre EHNA, IMC y CC. Conclusión: Se observó una elevada 
ocurrencia de EHNA, SM y FRCs en adolescentes obesos. Una 
fuerte correlación fue observada entre EHNA y SM, y entre FRCs 
y EHNA y SM. 
Descriptores: Adolescente; Obesidad Pediátrica; Hígado Gras;, 
Síndrome X Metabólico; Enfermedades Cardiovasculares.   
INTRODUCTION
The nonalcoholic fatty liver disease (NAFLD) covers 
all the spectrum of fatty liver diseases in individuals who 
drink little or no alcohol, ranging from hepatic steatosis 
to steatohepatitis and cirrhosis, being considered the main 
cause of chronic liver disease in both adult and pediatric 
populations(1,2).
The nonalcoholic hepatic steatosis (NAHS) in children 
is associated with obesity, insulin resistance (IR), metabolic 
syndrome (MS), and its components are cardiovascular risk 
factors (CRF)(3,4).
This disease has reached epidemic proportions in 
Western countries. In the United States, nearly 20% of the 
adult populations is estimated to have some manifestation 
of NAHS. The prevalence increases in the obese population, 
ranging from 75% to 92%. In children and adolescents, this 
prevalence ranges from 9.6% to 14%, reaching 38% in obese 
individuals. Similar values have been found in countries of 
Europe and Asia(5,6). In Brazil, there is no consistent data on 
the prevalence of NAHS in adult and pediatric population. 
However, studies have reported values ranging from 13.5% 
to 41.7% in the adult population, and occurrence from 2.6% 
to 57.4% in eutrophic and obese children, respectively(7-9).
The association of NAHS with MS suggests that the 
NAHS can be a hepatic component of the MS, representing 
an emerging health problem in different ethnical populations 
worldwide(10,11). In children and adolescents, it may lead 
to diabetes mellitus and cardiovascular diseases in adult 
life(3,12).
The prevalence of MS in the pediatric population 
changes according to the population studied and the 
criteria used in the assessment. However, recent studies 
show an occurrence ranging from 4.2% to 38.7% in both 
sexes(12,13). In the Brazilian population, the literature points 
to values ranging from 15.6% a 49.1%(11,14). It is a public 
health problem for young obese people, especially at 
post-pubescent age, when obesity is very likely to remain 
throughout adult life(14). In 10 years the prevalence of 
obesity and MS will considerably increase among age-
transition individuals (from children and adolescents to 
young adults) from 21% to 33.4%, and from 2.8% to 17.9% 
respectively(15). 
Additionally, in Brazil, the number of overweight male 
adolescents aged 10-19 years increased from 3.7% (1974-
1975) to 21.7% (2008-2009), and the number of overweight 
female adolescents went from 7.6% to 19.4% in the same 
period according to the Pesquisa de Orçamento Familiar – 
POF (Family Budget Survey)(16). 
Thus, this current study aimed to assess the association 
between nonalcoholic hepatic steatosis, metabolic syndrome 
and cardiovascular risk factors in obese adolescents. The 
results of this study will help in the development of strategies 
for health promotion and prevention and control of diseases 
in this population and hence minimize the onset of non-
communicable chronic diseases in overweight adolescents. 
METHODS
This is a quantitative observational cross-sectional 
study conducted from June to August 2011 in the city of 
Uberlândia, Minas Gerais (MG). 
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The sample comprised adolescents aged 14-19 years 
who were recruited through electronic and press publicity. 
Then, obese adolescents were referred to the department of 
endocrinology and cardiology of the Universidade Federal 
de Uberlândia – SECHC-UFU (Federal University of 
Uberlândia) for clinical assessment.
Of a total of 175 adolescents referred to SECHC-UFU, 
34 adolescents (14 males and 20 females) were selected 
through simple random probability sampling, meeting the 
inclusion criteria: body mass index (BMI) above the 95th 
percentile in the growth curve of the Center for Disease 
Control (CDC)(17) and sexual maturation(18,19). The study 
excluded adolescents who consumed alcohol and tobacco, 
and those who presented disabling diseases like rheumatic, 
neuromuscular, osteoarticular or degenerative disorders 
informed through medical reports.   
Adolescents wore light clothes and no shoes and 
then were weighted using a Filizola™ scale with a 150kg 
capacity and 100g accuracy. Height was measured using 
a Sanny™ wood stadiometer with 0.1cm accuracy. Body 
Mass Index (BMI) was calculated by dividing body mass 
(kg) by the square of the height (m).  
Presence of steatosis, measurements of visceral fat 
(VF) and subcutaneous fat (SF) were assessed using 
ultrasonography. The ultrasonographic aspect of steatosis 
was determined by the diffuse increased echogenicity, 
which can be noticed by comparing liver echogenicity with 
the echogenicity of the renal cortex or spleen(20). According 
to the diagnosis, steatosis was classified into degrees: mild 
(I), moderate (II) and severe (III) (21).     
VF was measured by placing a 3.5 MHz convex probe 
at 1 cm above the umbilical scar, considered as the measure 
between the rectus abdominis muscle and the anterior wall 
of abdominal aorta, quantified in centimeters(22). SF was 
measured using a 7.5MHz linear probe placed at 1 cm above 
the umbilical scar considering the measure between the skin 
and the external surface of the fascia of rectus abdominis 
muscle, quantified in centimeters(22).  
Metabolic syndrome among adolescents was 
characterized according to the criteria proposed by the 
International Diabetes Federation (IDF)(23), which considers 
that, for adolescents aged 10-16 years, the metabolic 
syndrome can be diagnosed by the presence of obesity and 
two other alterations (hypertriglyceridemia, low levels of 
high-density lipoprotein cholesterol (HDL-C), systemic 
blood pressure and fasting hyperglycemia)(23).  
The reference values used for adolescents aged 10-16 
years were: waist circumference (WC) ≥ the 90th percentile, 
triglycerides ≥ 150 mg/dL, HDL-C < 40 mg/dL, systolic 
blood pressure ≥ 130 and/or diastolic ≥ 85 mm Hg, fasting 
glycemia ≥ 100 mg/dL(23). For adolescents over 16 years old: 
waist circumference (WC) ≥ 90 cm for men and ≥ 80 cm for 
women(24), and two other factors: triglycerides ≥ 150 mg/
dL or specific treatment for this lipid disorder, HDL-C < 40 
mg/dL for boys and < 50 mg/dL girls or specific treatment 
for HDL-C, systolic blood pressure (SBP) ≥ 130 and/or 
diastolic (DBP) ≥ 85 mmHg or treatment for previously 
diagnosed hypertension and fasting glycemia ≥ 100 mg/dL 
or previous diagnosis of type 2 diabetes(23).  
The lipid and glucose profiles were determined by 
collecting 8 ml of blood through venous puncture after 
a 12-hour night fasting with previous normal diet. The 
lipid profile was determined using the spectrophotometric 
enzyme assay through the clinical chemistry kit (Abbott), 
except the high-density lipoprotein cholesterol (HDL-C), 
which was verified using the DiaSys Diagnostic Systems 
GmbH™ kit. The low-density lipoprotein cholesterol 
(LDL-C) was determined using Friedewald’s formula: 
LDL-C = TC – HDL-C – (Triglycerides/5)(25). The cutoff 
points adopted for the lipid profile were the values proposed 
by the III Diretriz Brasileira sobre Dislipidemia (Brazilian 
Guidelines for Dyslipidemia) (25).   
Plasma glucose level was measured using the 
spectrophotometric enzyme assay with the clinical 
chemistry kit (Abbott). The cutoff point used was the one 
established by the International Diabetes Federation (IDF)
(26).
Waist circumference was measured using SANY 
unextendable anthropometric tape which verified the 
millimeters of the medium point between the last rib and 
the iliac crest(27).  
The normality of data was verified through the 
Shapiro-Wilk test. Student’s t-test was used to check for 
differences of means between male and female genders. 
Pearson’s correlation test was applied to verify the relation 
between quantitative vs quantitative variables. The existing 
associations between qualitative variables were assessed by 
the Chi-squared test or Fisher’s Exact test when necessary. 
Data were analyzed using softwares SPSS version 17.0 and 
BioEstat version 5.0. The significance level was set at 5% 
(p ≤ 0.05). 
The study was approved by the Comitê de Ética em 
Pesquisa da Universidade Federal de Uberlândia – CEP/
UFU (Ethics Research Committee of the Federal University 
of Uberlândia) (No. 498/10). All the volunteers and their 
parents/caretakers were informed about the study and signed 
a free informed consent form (FICF) prior to participating 
in the research, respecting the Resolution 196/96 of the 
National Health Council.  
RESULTS 
In this current study, of the 175 adolescents referred 
to the research, 19.4% (n=34) were obese. In the sample 
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(n=34), it was observed that the mean BMI of volunteers 
corresponds to class II obesity (Table I).
No significant difference was found between genders for 
the variables age (M=16.5±1.7; F=16.9±1.5; p=0.42), BMI 
(M=35.2±3.9; F=35.2±4.1; p=0.97) and waist circumference 
(WC) (M=116.3±9.1; F=112.5±10.9; p=0.30). Only height 
(M=174.4±6.8; F=163.6±7.3; p=0.0001) and body mass 
(BM) (M=08.2±15.6; F=95.4±15.1; p=0.018) presented 
significant difference between genders, with a higher mean 
value for males. 
Table I - Anthropometric, biochemical and physiological data of obese adolescents. Uberlândia-MG, 2011.
 
AGE
(years)
HEIGHT
(m)
BM
(kg)
BMI
(kg/m2)
WC
(cm)
GLY
(mg/dL)
TG
(mg/dL)
HDL-C
(mg/dL)
SBP
(mmHg)
DBP
(mmHg)
Mean 16.8 1.7 101.2 35.7 114.3 82.5 134.7 45.8 127.06 81.18
SD 1.6 0.1 16.4 3.9 10.2 9.7 75.9 9.2 13.82 7.18
SD: standard deviation; BM: body mass; BMI: body mass index; WC: waist circumference; GLY: fasting glycemia; TG: triglycerides; 
HDL-C: high-density lipoprotein cholesterol; SBP: systolic blood pressure; DBP: diastolic blood pressure.
Table II - Distribution of metabolic syndrome (MS) and nonalcoholic hepatic steatosis (NAHS) according to gender of obese 
adolescents. Uberlândia-MG, 2011.
Variable
Male (n=14)
n%
Female (n=20)
n%
p
MS 9 64.3% 8 40% 0.2*
MS + NAHS 7 50% 7 35% 0.4*
*Chi-squared test. 
Table IV - Correlation between cardiovascular risk factors in obese adolescents. Uberlândia-MG, 2011.
BM BMI WC GLY TG HDL-C SBP DBP TC LDL-C
BM - 0.74** 0.85** -0.07 0.04 -0.32 0.58** 0.48** -0.22 -0.17
BMI 0.74** - 0.82** -0.28 -0.10 -0.05 0.37* 0.26 -0.16 -0.11
WC 0.85** 0.82** - -0.22 -0.02 -0.21 0.41* 0.36* -0.18 -0.12
GLY -0.07 -0.28 -0.22 - -0.37 0.17 -0.09 -0.15 -0.02 0.09
TG 0.04 -0.10 -0.02 -0.37 - -0.28 0.01 0.07 0.45* 0.08
HDL-C -0.32 -0.05 -0.21 0.17 -0.28 - -0.47** -0.27 0.15 -0.00
SBP 0.58** 0.37* 0.41* -0.09 0.01 -0.47** - 0.71** -0.28 -0.17
DBP 0.48** 0.26 0.36* -0.15 0.07 -0.27 0.71** - -0.30 -0.29
TC -0.22 -0.16 -0.18 -0.02 0.45* 0.15 -0.28 -0.30 - 0.88**
LDL-C -0.17 -0.11 -0.12 0.09 0.08 -0.00 -0.17 -0.29 0.88** -
BM: body mass; BMI: body mass index; WC: waist circumference; GLY: fasting glycemia; TG: Triglycerides; HDL-C: high-density 
lipoprotein cholesterol; SBP: systolic blood pressure; DBP: diastolic blood pressure; TC: total cholesterol; LDL-C: low-density lipoprotein 
cholesterol. Pearson’s correlation test. *p<0.05 and **p<0.01. 
Table III - Distribution of nonalcoholic hepatic steatosis (NAHS) and metabolic syndrome (MS) and disease staging 
according to gender of obese adolescents. Uberlândia-MG, 2011.
Variable 
Male (n=14)
n                     %
Female (n=20)
n                     %
p
NAHS 11 78.6% 15 75% 0.6#
NAHS + MS 7 50% 7 35% 0.4*
Stage I 6 42.8% 9 45% 0.9*
Stage II 4 28.6% 4 20% 0.4#
Stage III 1 7.1% 2 10% 0.6#
*Chi-squared test. #Fisher’s Exact test.
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All the volunteers presented an increase in WC, and 
26.5% (n=9), 52.9% (n=18), 32.3% (n=10), 35.3% (n=12) 
and 61.8% (n=21) of adolescents presented increased values 
of triglycerides, SBP, DBP, total cholesterol and LDL-C, 
respectively. Additionally, 52.9% (n=18) presented HDL-C 
values below reference values (64.3% for males and 45% 
for females). Only 8.8% (n=3) presented values above the 
cutoff point for fasting glucose.        
Half of the studied sample presented MS (n=17) and 
82.3% (n=14) of individuals who had MS also presented 
NAHS (Table II). There was a high incidence of NAHS 
(76.5%, n=26), with a higher prevalence of cases (88.5%, 
n=23) at the initial stages of the disease, and 53.8% (n=14) 
of individuals who had NAHS also presented MS (Table 
III). There was an association (p=0.02) between MS and 
NAHS in the studied sample (n=34). 
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Figure 1 - Associations of cardiovascular risk factors in obese adolescents with and without metabolic syndrome and nonalcoholic hepatic 
steatosis. TG: Triglycerides in mg/dL; SBP: systolic blood pressure in mmHg; DBP: diastolic blood pressure in mmHg; HDL-C: high-
density lipoprotein cholesterol in mg/dL; SM: metabolic syndrome; BMI: body mass index in kg/ m2; WC: waist circumference in cm; 
NAHS: nonalcoholic hepatic steatosis. A) TG in volunteers with and without SM. *p ≤ 0.05; B) SBP in volunteers with and without SM. 
*p ≤ 0.01; C) DBP in volunteers with and without SM. *p ≤ 0.05; D) HDL-C in volunteers with and without SM. *p ≤ 0.01; E) BMI in 
volunteers with and without NAHS. *p ≤ 0.01; F) WC in volunteers with and without NAHS. *p ≤ 0.05. All correlations were verified 
through Pearson’s correlation test.
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After the stratification by gender, males (n=14) 
presented a higher occurrence of MS along with NAHS 
(Table II and III). There was no association between MS 
and genders, NAHS and genders, and NHAS and its stages 
(Tables II and III).
It has also been verified in the sample (n=34) the 
occurrence of positive and negative correlations between 
cardiovascular risk factors: body mass and BMI, WC, 
SBP, DBP; body mass index and WC and SBP; waist 
circumference and SBP and DBP; total cholesterol and 
LDL-C and TG; HDL-C and SBP; SBP and DBP (Table 
IV). 
Figure 1 shows that individuals with MS (n=17) 
are significantly related to high levels of triglycerides, 
SBP, DBP and low levels of HDL-C when compared to 
individuals without MS. Adolescents with NAHS (n=26) 
are related to higher values of BMI and WC when compared 
to individuals without NAHS.
DISCUSSION
In this current study, 19.4% of individuals were obese, 
with BMI above the 95th percentile in the growth curve, and, 
according to the mean BMI, they presented class II obesity, 
which is associated with high risks of comorbidities(28).
The percentage of obesity found in this research is 
higher than the percentage (16.9%) found in the USA 
between 2009 and 2010(29) and the percentage (14.4%) 
found in a study conducted with Brazilian children and 
adolescents(30). It is significantly higher (5.9% in boys and 
4% in girls) than the percentage described by the POF 
conducted in Brazil between 2008 and 2009(16). 
The results found in this study, together with the results 
of other researchers(31,32), show that obesity in the pediatric 
population has significantly increased within a short time, 
pointing to a failure, up to now, in reverting this worldwide 
trend, which has major consequences on the quality of life 
and longevity of the human being. 
Environmental changes associated with modern society 
are responsible for the largest part of epidemic obesity, 
which results from a high percentage of fat that is kept 
through abnormal energy homeostasis(33). The main causes 
of this positive energy balance are the sedentary life and 
hypercaloric diet.   
In addition, overweight and obesity in the pediatric 
population is associated with puberty(34) , and there is a 
bigger change of the obese adolescent become an obese 
adult(28). A study conducted with Brazilian children and 
adolescents showed that overweight and obesity are directly 
related to sexual maturation. In this study, authors identified 
that 23.1% of interviewees were overweight or obese, 
with a higher prevalence of overweight in individuals who 
reported signs of sexual maturation, with no significant 
difference in overweight between genders(34). These results 
are similar to the results of this current study, in which there 
was no significant difference between the BMI of male and 
female post-pubescent adolescents.    
Obesity in children and adolescents is strongly 
associated with increased risks of premature cardiovascular 
diseases, MS and NAHS, leading to an increased rate of 
premature death for this population(29,31,32,35). Thus, this 
current study is in accordance with the literature because 
more than 50% of obese adolescents presented high 
occurrence of cardiovascular risk factors like WC, SBP, 
LDL-C above reference values and HDL-C below the 
reference values besides a great occurrence of NAHS and 
MS. 
The most common cardiovascular risk factor among 
the adolescents of this study was waist circumference. In 
all, 100% of adolescents presented values above the cutoff 
point preconized by the IDF(23,24). The percentages found 
are above 55% rate found by researchers in another study 
that was also conducted with Brazilian adolescents(36). The 
percentage found for waist circumference above the cutoff 
points is worrisome, for it suggests that, at least for boys, 
high values of waist circumference in adolescents may 
predict MS in adults(37). 
The findings of this current research did not show a 
significant occurrence of fasting hyperglycemia (8.8%). 
However, this has also been observed by other studies(13,14,36). 
In other studies conducted with adolescents, authors 
reported that fasting hyperglycemia was the less frequent 
risk factor(13,14). Another study conducted in Brazil showed 
an occurrence (2%) of fasting hyperglycemia as a risk 
factor; however, this percentage is still below the one found 
by research(36).
The occurrence of NAHS (76.5%) found in this 
study was above the one found in the literature for obese 
adolescents (38%)(5). However, another study(38) also found a 
high incidence of NAHS. In a sample of 861 obese children 
and adolescents, 587 (68.2%) presented NAHS.   
This high incidence of NAHS in the studied population 
points to a worrying situation since individuals with NAHS 
present a mortality rate that is 34% to 86% higher than the 
general population. One of the main causes of death are 
cardiovascular diseases(4), for they are related to factors that 
predict the development of coronary disease, dyslipidemia, 
central obesity and MS(38). 
Another worrying finding was that the metabolic 
syndrome was present in 50% of the participants of this 
study. This is above the 38.7% rate described for the 
general pediatric population(13) and above the 25.7% 
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incidence found in Asian children and adolescents(38) whose 
waist circumference parameters are used as a reference to 
the South American population in the characterization of 
MS(23,24).   
It has also been observed a joint occurrence of NAHS 
and MS (53.8%). The joint occurrence of NAHS and MS 
found in this study was similar to the one observed in a 
North American study in which researchers reported that 
50% of children and adolescents with NAHS presented 
MS(3).  
In fact, there was a correlation between MS, NAHS and 
cardiovascular risk factors. This finding is in accordance 
with a study that showed that the presence of hepatic 
steatosis can be considered a hepatic manifestation of the 
MS(10).
Additionally, there was a higher incidence of NAHS 
(78.6%) and MS (64.3%) among men versus 75% of NAHS 
and 40% of MS among women. Another Brazilian study 
conducted with adolescents also found a higher incidence 
of NAHS among men (19.5%) in relation to women (13%)
(39) but with a percentage difference that is smaller than the 
one found in this current research.  
Regarding the high prevalence of MS among men, a 
research conducted with North American adolescents using 
the criteria of the International Diabetes Federation for the 
identification of MS – the same criteria used in this current 
research – also found a higher incidence in men. However, 
it presented an incidence of 6.7% in men and 2.1% in 
women(40), values a lot smaller than the ones found in this 
study.  
During the same period of the study conducted in the 
USA, Brazilian researchers identified differences in the 
occurrence of MS between genders. The percentages found 
for Brazilian adolescents were 34.8% for men and 15.6% for 
women(11). The percentage found for Brazilian adolescents 
was smaller than the one found in the USA; however, this 
percentage is still smaller than the one identified in this 
current study.  
Recently, a research conducted with Brazilian 
adolescents found values similar to the ones found in this 
study. Researchers verified an incidence of 49.1% of MS 
in men; however, the occurrence (26.9%) in women(14) was 
still smaller than the percentage found in this study. 
The physiological relations between the high incidence 
of NAHS and MS in male adolescents are still not described 
by the literature. However, it is believed that this higher 
incidence of NAHS and MS in male post-pubescent 
adolescents may be strongly related to the topographic 
difference of the distribution of body fat between genders 
and the influence of sexual hormones. 
The size of the sample is a limitation to this current 
study. Therefore, there should be studies conducted with a 
larger number of individuals to confirm the findings in the 
studied population. 
However, this is an important issue since there are 
high chances, from 50% to 70%, of obese adolescents 
remain obese in adult life(28). There is a need to develop 
effective therapeutic, preventive, educative and health 
promotion strategies for this population since NAHS, 
MS, cardiovascular diseases and obesity can be prevented 
through physical activity and a healthy diet.
CONCLUSION
There was a high incidence of NAHS, MS and 
cardiovascular risk factors in obese adolescents, with a 
higher prevalence among men. It was also verified that 
NAHS and MS are related to cardiovascular risk factors like 
the body mass index, waist circumference, triglycerides, 
systolic and diastolic blood pressure, and low levels of 
HDL-C.  
Also, there was a strong correlation between NAHS and 
MS and CRF since obese adolescents with NAHS presented 
higher chances of developing MS and cardiovascular 
diseases, pointing to the need for multiprofessional 
interventions. 
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